A personalised cancer vaccine designed to boost the body's own natural defences when used alongside chemotherapy shows 'promising signs' after a clinical trial. They use these proteins to create tailor-made vaccines for each individual cancer patients and then administer them alongside immunotherapy drug atezolizumab. Using this information, they were able to design a type of cancer vaccine known as messenger RNA vaccine, which can be tailored to target the 'unique differences' in tumours of every cancer patient. The personalised treatment was well tolerated, with patients largely experiencing low-to-moderate side effects, the researchers said. This is a response to the personalised vaccine treatment, the research team claim.

Source: Daily Mail June 22, 2020 12:35 UTC